IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Optimi Health Corp (OPTH)

CUSIP: 68405H308 | NYSE | Healthcare · Drug Manufacturers - Specialty & Generic | Micro Cap | 13 institutional holders

Quarters

Q3 2026Q2 2026
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13G/AMark Angelo173,0003.0%Newly reportedSep 30, 2026No 13F filer matched
13GCathay Visions Enterprises Inc.474,1248.3%New 5%+ stakeMay 19, 2026

Institutional Holders — Q3 2026

AdvisorShares Investments LLC260,427
0.2% of portfolio›$1.2M
StoneX Group Inc.11,041
0.0% of portfolio›$53.4K
TD Waterhouse Canada Inc.333
0.0% of portfolio›$1.5K
Rydar Equities, Inc.33
0.0% of portfolio›$133
StyleTurnoverLocationFiled
AdvisorShares Investments LLC
260,427$1.2M0.2%Deep ValueVery HighBethesda, MD2026-11-09
StoneX Group Inc.
11,041$53.4K0.0%ETFMediumNew York, NY2026-11-03
TD Waterhouse Canada Inc.
333$1.5K0.0%CoreLowToronto, Australia2026-10-16
Rydar Equities, Inc.
33$1330.0%CoreVery LowWeatherford, TX2026-10-13
No 13F filer matched
13G/AMark Angelo173,000
3.0% of class · Sep 30, 2026Newly reported
No 13F filer matched
13GCathay Visions Enterprises Inc.474,124
8.3% of class · May 19, 2026New 5%+ stake
No 13F filer matched